| pubmed-article:19903661 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19903661 | lifeskim:mentions | umls-concept:C0022661 | lld:lifeskim |
| pubmed-article:19903661 | lifeskim:mentions | umls-concept:C0403447 | lld:lifeskim |
| pubmed-article:19903661 | lifeskim:mentions | umls-concept:C0014025 | lld:lifeskim |
| pubmed-article:19903661 | lifeskim:mentions | umls-concept:C0009429 | lld:lifeskim |
| pubmed-article:19903661 | lifeskim:mentions | umls-concept:C0717550 | lld:lifeskim |
| pubmed-article:19903661 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:19903661 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:19903661 | pubmed:dateCreated | 2010-2-26 | lld:pubmed |
| pubmed-article:19903661 | pubmed:abstractText | Dual blockade of the renin-angiotensin system (RAS) has been claimed to have a specific renal protective effect in chronic kidney disease (CKD). The present short-term study reports on the feasibility of dual blockade in a consecutive group of patients with CKD stage 3-5. | lld:pubmed |
| pubmed-article:19903661 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19903661 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903661 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19903661 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903661 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903661 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903661 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903661 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903661 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903661 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19903661 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:19903661 | pubmed:issn | 1460-2385 | lld:pubmed |
| pubmed-article:19903661 | pubmed:author | pubmed-author:KamperAnne-Li... | lld:pubmed |
| pubmed-article:19903661 | pubmed:author | pubmed-author:StrandgaardSv... | lld:pubmed |
| pubmed-article:19903661 | pubmed:author | pubmed-author:Frimodt-Mølle... | lld:pubmed |
| pubmed-article:19903661 | pubmed:author | pubmed-author:Høj... | lld:pubmed |
| pubmed-article:19903661 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19903661 | pubmed:volume | 25 | lld:pubmed |
| pubmed-article:19903661 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19903661 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19903661 | pubmed:pagination | 842-7 | lld:pubmed |
| pubmed-article:19903661 | pubmed:meshHeading | pubmed-meshheading:19903661... | lld:pubmed |
| pubmed-article:19903661 | pubmed:meshHeading | pubmed-meshheading:19903661... | lld:pubmed |
| pubmed-article:19903661 | pubmed:meshHeading | pubmed-meshheading:19903661... | lld:pubmed |
| pubmed-article:19903661 | pubmed:meshHeading | pubmed-meshheading:19903661... | lld:pubmed |
| pubmed-article:19903661 | pubmed:meshHeading | pubmed-meshheading:19903661... | lld:pubmed |
| pubmed-article:19903661 | pubmed:meshHeading | pubmed-meshheading:19903661... | lld:pubmed |
| pubmed-article:19903661 | pubmed:meshHeading | pubmed-meshheading:19903661... | lld:pubmed |
| pubmed-article:19903661 | pubmed:meshHeading | pubmed-meshheading:19903661... | lld:pubmed |
| pubmed-article:19903661 | pubmed:meshHeading | pubmed-meshheading:19903661... | lld:pubmed |
| pubmed-article:19903661 | pubmed:meshHeading | pubmed-meshheading:19903661... | lld:pubmed |
| pubmed-article:19903661 | pubmed:meshHeading | pubmed-meshheading:19903661... | lld:pubmed |
| pubmed-article:19903661 | pubmed:meshHeading | pubmed-meshheading:19903661... | lld:pubmed |
| pubmed-article:19903661 | pubmed:meshHeading | pubmed-meshheading:19903661... | lld:pubmed |
| pubmed-article:19903661 | pubmed:meshHeading | pubmed-meshheading:19903661... | lld:pubmed |
| pubmed-article:19903661 | pubmed:meshHeading | pubmed-meshheading:19903661... | lld:pubmed |
| pubmed-article:19903661 | pubmed:meshHeading | pubmed-meshheading:19903661... | lld:pubmed |
| pubmed-article:19903661 | pubmed:meshHeading | pubmed-meshheading:19903661... | lld:pubmed |
| pubmed-article:19903661 | pubmed:meshHeading | pubmed-meshheading:19903661... | lld:pubmed |
| pubmed-article:19903661 | pubmed:meshHeading | pubmed-meshheading:19903661... | lld:pubmed |
| pubmed-article:19903661 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:19903661 | pubmed:articleTitle | Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease. | lld:pubmed |
| pubmed-article:19903661 | pubmed:affiliation | Department of Nephrology, Herlev Hospital, Denmark . marfri01@heh.regionh.dk | lld:pubmed |
| pubmed-article:19903661 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19903661 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
